Autonomic Determinants of POTS - Pilot1

NCT04050410 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Postural Tachycardia Syndrome

Interventions

DRUG: Moxonidine
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]